Who is sponsoring NCT01736358?

NCT01736358 is sponsored by Montefiore Medical Center.

What condition does NCT01736358 study?

NCT01736358 studies Postoperative Pain Management, Urolithiasis.

What drugs are being tested in NCT01736358?

Interventions: Intranasal Ketoralac, Placebo.

What is the status of NCT01736358?

NCT01736358 is currently TERMINATED.

Last reviewed 2020-02-03 · How we verify

Evaluating Post-operative Pain Management Efficacy of Intra Nasal Ketorolac in Ambulatory Urological Surgeries-A Randomized Double-blinded Placebo Controlled Study

NCT01736358 Phase 4 TERMINATED Results posted

Despite an overall reduction in the perioperative complication rate, post operative pain management after ureteroscopic removal of stones (URS) remains a major factor delaying discharge of patients. The investigators hypothesize that perioperative usage of intranasal ketorolac will provide a reduction in post operative opioid requirements, better post operative pain control, higher anesthesia satisfaction and faster recovery.

Details

Lead sponsor	Montefiore Medical Center
Phase	Phase 4
Status	TERMINATED
Enrolment	50
Start date	2012-10
Completion	2014-06

Conditions

Postoperative Pain Management
Urolithiasis

Interventions

Intranasal Ketoralac
Placebo

Primary outcomes

Post-operative Opioid Requirements — 3 hours after surgery
this study will assess the effect of perioperative usage of single-dose of intranasal ketorolac on post operative opioid requirements within 3 hours after surgery.

Countries

United States